Utility and cost‐effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients

Obstetrics and Gynecology

Volumn 99, Issue 5, 2002, Pages 771-776

  Horowitz, Neil S ^a   Gibb, Randall K ^a   Menegakis, Nicole E ^a   Mutch, David G ^a   Rader, Janet S ^a   Herzog, Thomas J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC DISEASE; HOSPITALIZATION; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; OVARY CARCINOMA; PERITONEUM PSEUDOMYXOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SALPINGOOOPHORECTOMY; UTERINE CERVIX CARCINOMA;

BLOOD DONORS; BLOOD TRANSFUSION, AUTOLOGOUS; COST-BENEFIT ANALYSIS; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES;

EID: 0036227105     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200205000-00017     Document Type: Article

References (24)

1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts. Blood transfusion. N Engl J Med 1999;340:438-47.
2. Aubuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the non-hospital setting. Transfusion 1991;31:513-7.
3. Mann M, Sacks HT, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially “high risk” patients. Transfusion 1983;235:229-32.
4. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts. Blood conservation. N Engl J Med 1999;340:525-33.
5. Goldfinger D, Haimowitz M, AuBuchon JP, Birkmeyer JD. Controversies in transfusion medicine: Is autologous blood transfusion worth the cost? Pro and con. Transfusion 1994;34:75-83.
6. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsu PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993;33:544-51.
7. Marchetti M, Barosi G. Cost-effectiveness of epoetin and autologous blood donation in reducing allogeneic blood transfusions in coronary artery bypass graft surgery. Transfusion 2000;40:673-81.
8. Goodnough LM, Grishaber JE, Birkmeyer JD, Monk TG, Catalona WJ. Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 1994;44:226-31.
9. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
10. Kanter MH, van Maanen D, Anders KH, Castro F, Win Maya W, Clark K. Preoperative autologous blood donations before elective hysterectomy. JAMA 1996;276:798-801.
11. Benjamin I, Barakat RR, Curtin JP, Jones WB, Lewis JL, Hoskins WJ. Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infection. Obstet Gynecol 1994;84:974-8.
12. Wang C, Lau W, Herst R, Drutz H, Fernandes B. Preoperative autologous blood deposition in support of gynaecological repair procedures. Transfus Med 1998;8:23-7.
13. Gargano G, Fanizza G, Polignano G, Lorusso V, De Lena M. A new protocol of iron therapy combined with epoetin alpha as a treatment for preoperative autologous blood donation in gynaecological tumor surgery. Oncol Rep 1999;6:1349-52.
14. Kanter MH, van Maanen D, Anders KH, Castro F, Win Mya W, Clark K. A study of an educational intervention to decrease inappropriate preoperative autologous blood donation: Its effectiveness and the effect on subsequent transfusion rates in elective hysterectomy. Transfusion 1999;39:801-7.
15. Hockal M, Vaupal P. Biologic consequences of tumor hypoxia. Semin Oncol 2001;2(Suppl. 8):36-41.
16. Obermair A, Chek R, Horwood K, Janda M, Bachtiary B, Schwanzelberger B, et al. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: Preliminary results. Cancer 2001;92:903-8.
17. Grogan M, Thomas GM, Melamed I, Wong FL, Pearcy RG, Joseph PK, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
18. Monk BJ, Tewari K, Gamboa-Vujicic G, Burger RA, Manetta A, Berman ML. Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy. Obstet Gynecol 1995; 85:343-8.
19. Kruskall MS, Yomtovian R, Dzik WH, Friedman KD, Umlas J. On improving the cost effectiveness of autologous blood transfusion practices. Transfusion 1994;34:259-64.
20. Renner SW, Howanitz PJ, Bachner P. Preoperative autologous blood donation in 612 hospitals: A College of American Pathologists' Q-probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1992;116:613-9.
21. Blum LN, Allen JR, Genel M, Howe JP III. Crossover use of donated blood for autologous transfusions: Report of the Council on Scientific Affairs, American Medical Association. Transfusion 1998;38:891-5.
22. Rosenblatt MA, Cantos EM, Mohandas K. Intraoperative hemodilution is more cost-effective than preoperative autologous donation for patients undergoing procedures associated with a low risk for transfusion. Clin Anesth 1997;9:26-9.
23. Goodnough LT, Monk TG, Brecher ME. Acute normovolemic hemodilution in surgery. Hematology 1997;2:413-20.
24. Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion 1992;32:226-30.